Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

In gastroschisis, there is evidence to suggest that gut dysfunction develops secondary to bowel inflammation; we aimed to evaluate the effect of maternal antenatal corticosteroids administered for obstetric reasons on time to full enteral feeds in a multicenter cohort study of gastroschisis infants. A three center, retrospective cohort study (1992-2013) with linked fetal/neonatal gastroschisis data was conducted. The primary outcome measure was time to full enteral feeds (a surrogate measure for bowel function) and secondary outcome measure was length of hospital stay. Analysis included Mann-Whitney and Cox regression. Of 500 patients included in the study, 69 (GA at birth 34 [25-38] weeks) received antenatal corticosteroids and 431 (GA at birth 37 [31-41] weeks) did not. Antenatal corticosteroids had no effect on the rate of reaching full feeds (Hazard ratio HR 1.0 [95% CI: 0.8-1.4]). However, complex gastroschisis (HR 0.3 [95% CI: 0.2-0.4]) was associated with an increased time to reach full feeds and later GA at birth (HR 1.1 per week increase in GA [95% CI: 1.1-1.2]) was associated with a decreased time to reach full feeds. Maternal antenatal corticosteroids use, under current antenatal steroid protocols, in gastroschisis is not associated with an improvement in neonatal outcomes such as time to full enteral feeds or length of hospital stay. © 2020 The Authors. Prenatal Diagnosis published by John Wiley & Sons Ltd.


Helen Carnaghan, Catherine P James, Paul B Charlesworth, Marco Ghionzoli, Susana Pereira, Mohamed Elkhouli, David Baud, Paolo De Coppi, Greg Ryan, Prakesh S Shah, Mark Davenport, Anna L David, Agostino Pierro, Simon Eaton, Gastroschisis Study Group. Antenatal corticosteroids and outcomes in gastroschisis: A multicenter retrospective cohort study. Prenatal diagnosis. 2020 Jul;40(8):991-997

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 32400889

View Full Text